Kestra Advisory Services, LLC Applied Genetic Technologies Corp Transaction History

Kestra Advisory Services, LLC

  • $17.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022
SELL
$0.29 - $0.89 $145 - $445
-500 Reduced 1.46%
33,800 $9 Million
Q2 2022

Aug 12, 2022
BUY
$0.62 - $1.1 $372 - $660
600 Added 1.78%
34,300 $26,000
Q1 2022

Apr 26, 2022
BUY
$1.07 - $2.71 $6,099 - $15,447
5,700 Added 20.36%
33,700 $36,000
Q4 2021

Jan 20, 2022
BUY
$1.87 - $2.91 $52,360 - $81,480
28,000 New
28,000 $53,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email